Intramuscular testosterone
Showing 1 - 25 of 2,036
Hypogonadism, Male, Fatigue Syndrome, Chronic Trial in Boston, Seattle (Testosterone Undecanoate 750 MG/3 ML Intramuscular
Recruiting
- Hypogonadism, Male
- Fatigue Syndrome, Chronic
- Testosterone Undecanoate 750 MG/3 ML Intramuscular Solution [AVEED]
- placebo
-
Boston, Massachusetts
- +1 more
Aug 11, 2022
Hypogonadism Trial in DeLand, Miami (Test formulation, Reference formulation)
Completed
- Hypogonadism
- Test formulation
- Reference formulation
-
DeLand, Florida
- +1 more
Apr 2, 2021
Testosterone Deficiency, Hypogonadism, Male Trial in Chestnut Hill (Testosterone)
Completed
- Testosterone Deficiency
- Hypogonadism, Male
-
Chestnut Hill, MassachusettsMen's Health Boston
Sep 27, 2019
Health Services for Transgender Persons, Transgender Persons Trial in Portland (drug, behavioral, other)
Unknown status
- Health Services for Transgender Persons
- Transgender Persons
- Testosterone injection
- +3 more
-
Portland, OregonOregon Health and Science University
Aug 19, 2019
Stress Urinary Incontinence, Menopause Trial (Testosterone cypionate, Placebo)
Not yet recruiting
- Stress Urinary Incontinence
- Menopause
- Testosterone cypionate
- Placebo
- (no location specified)
Oct 30, 2023
Hypogonadism, Peripheral Vascular Disease, Type 2 Diabetes Trial in Barnsley (Testosterone, saline)
Completed
- Hypogonadism
- +2 more
-
Barnsley, South Yorkshire, United KingdomBarnsley Hospital NHS Foundation Trust
May 18, 2022
Prostate Cancer Trial in Baltimore (DFMO, testosterone cypionate, Luteinizing hormone-releasing hormone (LHRH) analogue)
Not yet recruiting
- Prostate Cancer
- DFMO
- +3 more
-
Baltimore, MarylandJohns Hopkins University: Sidney Kimmel Comprehensive Cancer Cen
Sep 22, 2023
Opioid Use, Pain, Hypogonadism, Male Trial in Boston (Testosterone Undecanoate 250 MG/ML, Placebo)
Recruiting
- Opioid Use
- +2 more
- Testosterone Undecanoate 250 MG/ML
- Placebo
-
Boston, MassachusettsBrigham and Women's Hospital
Sep 16, 2022
Pain, Opioid Use, Androgen Deficiency Trial in Boston (Testosterone Cypionate, Placebo)
Recruiting
- Pain
- +2 more
- Testosterone Cypionate
- Placebo
-
Boston, MassachusettsBrigham and Women's Hospital
Apr 26, 2022
Castration Resistant Metastatic Prostate Cancer Trial in Baltimore (Testosterone cypionate, Enzalutamide, Testosterone
Recruiting
- Castration Resistant Metastatic Prostate Cancer
- Testosterone cypionate
- +2 more
-
Baltimore, MarylandJohns Hopkins University/Sidney Kimmel Cancer Center
Aug 4, 2022
Facioscapulohumeral Muscular Dystrophy Trial in Rochester (Testosterone Enanthate, Somatropin)
Completed
- Facioscapulohumeral Muscular Dystrophy
- Testosterone Enanthate
- Somatropin
-
Rochester, New YorkUniversity of Rochester
Jun 7, 2022
Urinary Incontinence, Menopause Trial (Testosterone Enanthate, Placebo)
Withdrawn
- Urinary Incontinence
- Menopause
- Testosterone Enanthate
- Placebo
- (no location specified)
Jul 18, 2022
Spinal Cord Injury, Spinal Cord Injuries, Trauma, Nervous System Trial in Tampa, Gainesville (Testosterone Enanthate,
Terminated
- Spinal Cord Injury
- +10 more
- Testosterone Enanthate
- +3 more
-
Tampa, Florida
- +1 more
Jul 28, 2022
Bariatric Surgery Candidate, Male Hypogonadism, Muscle Loss Trial in Esbjerg (Testosterone Undecanoate)
Recruiting
- Bariatric Surgery Candidate
- +2 more
- Testosterone Undecanoate
-
Esbjerg, DenmarkHospitalSWD
Oct 24, 2022
Rotator Cuff Tears Trial in Sioux Falls (Testosterone cypionate, Placebos)
Withdrawn
- Rotator Cuff Tears
- Testosterone cypionate
- Placebos
-
Sioux Falls, South DakotaOrthopedic Institute
Feb 28, 2022
Prostate Cancer, Castration-resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Baltimore
Recruiting
- Prostate Cancer
- +2 more
- Testosterone Undecanoate
- Enzalutamide
-
Baltimore, MarylandJohns Hopkins Hospital
May 6, 2022
Drug Interaction Trial in Bangkok (Emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg (F/TDF) and emtricitabine 200
Recruiting
- Drug Interaction
- Emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg (F/TDF) and emtricitabine 200 mg/tenofovir alafenamide 25 mg (F/TAF)
-
Bangkok, Pathumwan, ThailandInstitute of HIV Research and Innovation (IHRI)
Apr 21, 2022
COPD Trial in Galveston (Testosterone Enanthate, Placebo)
Withdrawn
- COPD
- Testosterone Enanthate
- Placebo
-
Galveston, TexasUniversity of Texas Medical Branch
Jan 18, 2022
Androgen Deprivation-related Sarcopenia
Recruiting
- Metastatic Prostate Cancer
- Androgen Deprivation Therapy
- GnRH agonist
-
Seattle, WashingtonVeterans Affairs Puget Sound Health Care System
Mar 16, 2022
Bone Metabolism Trial in Boston (testosterone cypionate)
Withdrawn
- Bone Metabolism
- testosterone cypionate
-
Boston, MassachusettsMassachusetts General Hospital
Oct 22, 2021
MDD Trial in Zürich (Male-specific psychotherapeutic program (MSPP), Cognitive beahvioral therapy (CBT))
Not yet recruiting
- Major Depressive Disorder
- Male-specific psychotherapeutic program (MSPP)
- Cognitive beahvioral therapy (CBT)
-
Zürich, SwitzerlandAmbulatory for Cognitive Behavioral Therapy and Behavioral Medic
Jun 22, 2022
Prostate Cancer, Castration-Resistant Prostate Cancer Trial in Aurora (Transdermal Testosterone, Standard of Care, Enzalutamide)
Active, not recruiting
- Prostate Cancer
- Castration-Resistant Prostate Cancer
- Transdermal Testosterone
- Standard of Care, Enzalutamide
-
Aurora, ColoradoUniversity of Colorado Hospital
Jan 31, 2022
Muscle, Fat and Tissue Receptors
Active, not recruiting
- Gender Incongruence
- Transgenderism
- testosterone cypionate
- Estradiol Valerate
-
Saint Louis, MissouriSaint Louis Univeristy
Jan 13, 2023
Castration-resistant Prostate Cancer, Homologous Recombination Deficiency Trial in Sydney (Testosterone Enanthate 100 MG/ML
Recruiting
- Castration-resistant Prostate Cancer
- Homologous Recombination Deficiency
- Testosterone Enanthate 100 MG/ML Injectable Solution
- Testosterone Enanthate 100 MG/ML Injectable Solution / Carboplatin AUC 5
-
Sydney, New South Wales, AustraliaKinghorn Cancer Centre, St. Vincent's Hospital
Dec 16, 2022